Labcorp Holdings annual net debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Net Debt Growth & History (LH)
Labcorp Holdings's net debt was $5.99B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.99B | $239.6M | +4.16% |
| 2024 | 2024-12-31 | $5.75B | $336.7M | +6.22% |
| 2023 | 2023-12-31 | $5.42B | −$508.4M | −8.58% |
| 2022 | 2022-12-31 | $5.93B | $1.06B | +21.68% |
| 2021 | 2021-12-31 | $4.87B | −$565.7M | −10.41% |
| 2020 | 2020-12-31 | $5.44B | −$1.33B | −19.71% |
| 2019 | 2019-12-31 | $6.77B | $1.10B | +19.39% |
| 2018 | 2018-12-31 | $5.67B | −$885.3M | −13.50% |
| 2017 | 2017-12-31 | $6.56B | $1.03B | +18.60% |
| 2016 | 2016-12-31 | $5.53B | −$224.6M | −3.90% |
| 2015 | 2015-12-31 | $5.75B | $3.24B | +128.67% |
| 2014 | 2014-12-31 | $2.52B | −$110.2M | −4.20% |
| 2013 | 2013-12-31 | $2.63B | $374.7M | +16.65% |
| 2012 | 2012-12-31 | $2.25B | $189.3M | +9.18% |
| 2011 | 2011-12-31 | $2.06B | $32.6M | +1.61% |
| 2010 | 2010-12-31 | $2.03B | $783.2M | +62.86% |
| 2009 | 2009-12-31 | $1.25B | −$255.7M | −17.03% |
| 2008 | 2008-12-31 | $1.50B | — | — |
Labcorp Holdings quarterly net debt
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.62B | $1.23B | +22.69% |
| Q1 2026 | 2026-03-31 | $6.26B | $109.7M | +1.78% |
| Q4 2025 | 2025-12-31 | $5.99B | $239.6M | +4.16% |
| Q3 2025 | 2025-09-30 | $5.43B | $630.0M | +13.12% |
| Q2 2025 | 2025-06-30 | $5.40B | $1.71B | +46.30% |
| Q1 2025 | 2025-03-31 | $6.15B | $2.32B | +60.67% |
| Q4 2024 | 2024-12-31 | $5.75B | $336.7M | +6.22% |
| Q3 2024 | 2024-09-30 | $4.80B | $190.9M | +4.14% |
| Q2 2024 | 2024-06-30 | $3.69B | −$287.8M | −7.23% |
| Q1 2024 | 2024-03-31 | $3.83B | −$1.77B | −31.60% |
| Q4 2023 | 2023-12-31 | $5.42B | −$508.4M | −8.58% |
| Q3 2023 | 2023-09-30 | $4.61B | −$1.25B | −21.31% |
| Q2 2023 | 2023-06-30 | $3.98B | −$1.27B | −24.16% |
| Q1 2023 | 2023-03-31 | $5.60B | $539.4M | +10.67% |
| Q4 2022 | 2022-12-31 | $5.93B | $1.06B | +21.68% |
| Q3 2022 | 2022-09-30 | $5.86B | $1.56B | +36.35% |
| Q2 2022 | 2022-06-30 | $5.25B | $852.8M | +19.41% |
| Q1 2022 | 2022-03-31 | $5.06B | $1.09B | +27.43% |
| Q4 2021 | 2021-12-31 | $4.87B | −$565.7M | −10.41% |
| Q3 2021 | 2021-09-30 | $4.30B | −$1.72B | −28.57% |
| Q2 2021 | 2021-06-30 | $4.39B | −$2.16B | −33.01% |
| Q1 2021 | 2021-03-31 | $3.97B | −$2.83B | −41.59% |
| Q4 2020 | 2020-12-31 | $5.44B | −$1.33B | −19.71% |
| Q3 2020 | 2020-09-30 | $6.02B | −$1.06B | −14.98% |
| Q2 2020 | 2020-06-30 | $6.56B | −$684.7M | −9.46% |
| Q1 2020 | 2020-03-31 | $6.79B | $323.3M | +5.00% |
| Q4 2019 | 2019-12-31 | $6.77B | $1.10B | +19.39% |
| Q3 2019 | 2019-09-30 | $7.08B | $1.45B | +25.69% |
| Q2 2019 | 2019-06-30 | $7.24B | $1.62B | +28.71% |
| Q1 2019 | 2019-03-31 | $6.47B | −$8.3M | −0.13% |
| Q4 2018 | 2018-12-31 | $5.67B | −$885.3M | −13.50% |
| Q3 2018 | 2018-09-30 | $5.63B | −$1.25B | −18.12% |
| Q2 2018 | 2018-06-30 | $5.63B | −$263.3M | −4.47% |
| Q1 2018 | 2018-03-31 | $6.48B | $860.6M | +15.32% |
| Q4 2017 | 2017-12-31 | $6.56B | $1.03B | +18.60% |
| Q3 2017 | 2017-09-30 | $6.88B | $1.20B | +21.21% |
| Q2 2017 | 2017-06-30 | $5.89B | $406.9M | +7.42% |
| Q1 2017 | 2017-03-31 | $5.62B | −$148.5M | −2.58% |
| Q4 2016 | 2016-12-31 | $5.53B | −$224.6M | −3.90% |
| Q3 2016 | 2016-09-30 | $5.67B | −$351.8M | −5.84% |
| Q2 2016 | 2016-06-30 | $5.48B | −$743.6M | −11.94% |
| Q1 2016 | 2016-03-31 | $5.77B | −$790.9M | −12.06% |
| Q4 2015 | 2015-12-31 | $5.75B | $3.24B | +128.67% |
| Q3 2015 | 2015-09-30 | $6.03B | $3.56B | +144.33% |
| Q2 2015 | 2015-06-30 | $6.23B | $3.68B | +144.06% |
| Q1 2015 | 2015-03-31 | $6.56B | $3.87B | +144.05% |
| Q4 2014 | 2014-12-31 | $2.52B | −$110.2M | −4.20% |
| Q3 2014 | 2014-09-30 | $2.47B | −$23.7M | −0.95% |
| Q2 2014 | 2014-06-30 | $2.55B | $152.6M | +6.36% |
| Q1 2014 | 2014-03-31 | $2.69B | $550.0M | +25.74% |
| Q4 2013 | 2013-12-31 | $2.63B | $374.7M | +16.65% |
| Q3 2013 | 2013-09-30 | $2.49B | $295.7M | +13.48% |
| Q2 2013 | 2013-06-30 | $2.40B | $413.4M | +20.82% |
| Q1 2013 | 2013-03-31 | $2.14B | $145.6M | +7.31% |
| Q4 2012 | 2012-12-31 | $2.25B | $189.3M | +9.18% |
| Q3 2012 | 2012-09-30 | $2.19B | $296.3M | +15.61% |
| Q2 2012 | 2012-06-30 | $1.99B | $100.8M | +5.35% |
| Q1 2012 | 2012-03-31 | $1.99B | −$17.8M | −0.89% |
| Q4 2011 | 2011-12-31 | $2.06B | $32.6M | +1.61% |
| Q3 2011 | 2011-09-30 | $1.90B | $648.7M | +51.93% |
| Q2 2011 | 2011-06-30 | $1.88B | $665.4M | +54.59% |
| Q1 2011 | 2011-03-31 | $2.01B | $853.2M | +73.80% |
| Q4 2010 | 2010-12-31 | $2.03B | $783.2M | +62.86% |
| Q3 2010 | 2010-09-30 | $1.25B | −$24.9M | −1.95% |
| Q2 2010 | 2010-06-30 | $1.22B | $33.7M | +2.84% |
| Q1 2010 | 2010-03-31 | $1.16B | — | — |
| Q4 2009 | 2009-12-31 | $1.25B | −$255.7M | −17.03% |
| Q3 2009 | 2009-09-30 | $1.27B | — | — |
| Q2 2009 | 2009-06-30 | $1.19B | — | — |
| Q4 2008 | 2008-12-31 | $1.50B | — | — |
Labcorp Holdings net debt trends
Over the last five fiscal years, Labcorp Holdings's net debt increased from $5.44B to $5.99B, a change of $558.1M. The latest reported quarter, Q2 2026, shows $6.62B.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...